Skip to main content
Figure 2 | BMC Research Notes

Figure 2

From: Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients

Figure 2

Cumulative survival (A), and cumulative recurrence free survival (B) of patients who underwent surgery for EOC, were plotted in accordance with Kaplan-Meier survival analysis. Patients who presented with advanced stage (FIGO III, IV) cancer had significantly less favorable prognosis if their tumor expressed GdA (A) and their cumulative recurrence free survival was also significantly shortened (B). Statistical significance for all tests was assumed for p < 0.05.

Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us